foxo4-dri peptide senolytic 2023 2024 study ES2 rapidly destroys TP53-FOXO4 foci leading to TP53 mediated FOXO4-DRI 10mg
FOXO4 DRI 10mg FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $6.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16



